An exploratory study on the accuracy of tissue diagnosis using transvaginal ultrasound and aspiration endometrial sampling equipment in screening for endometrial hyperplasia and uterine cancer in asymptomatic women undergoing physical and occupational health examinations.

An exploratory study on the accuracy of tissue diagnosis using transvaginal ultrasound and aspiration endometrial sampling equipment in screening for endometrial hyperplasia and uterine cancer in asymptomatic women undergoing physical and occupational health examinations. - An exploratory study on the accuracy of tissue diagnosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057252

Enrollment

800

Registered

2025-04-01

Start date

2025-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial hyperplasia and uterine cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Those who are able to obtain consent by September 2034 after approval by the director of the facility 2) Females between the ages of 40 and 65 at the time of consent 3) Those who wish to have endometrial tissue diagnosis as a screening for uterine cancer 4) Patients who have undergone gynecological asymptomatic checkups and workplace gynecological checkups at Bene Asakusa Health Screening Center.

Exclusion criteria

Exclusion criteria: (1) Those who have refused to provide information (2) Those who have symptoms such as irregular bleeding (3) Pregnancy or the possibility of pregnancy (4) Have an abnormality in blood coagulation (5) Other patients who are deemed ineligible by the physician.

Design outcomes

Primary

Measure	Time frame
(1) The presence or absence of genital bleeding after the examination is counted. (2) The frequency of progression from endometrial hyperplasia to uterine cancer is counted. (3) Accuracy and superiority of examination and diagnosis	—

Secondary

Measure	Time frame
(1) The incidence of pain during examination of endometrial histology using a suction-type endometrial sampling device, the rate at which the device can be inserted, the frequency of bleeding, and the absence or presence of pain (degree I, II, and III) will be tabulated. (2) Detection of lesions other than endometrial hyperplasia and uterine cancer	—

Countries

Japan

Contacts

Public ContactNatuki Naobayashi

Medical Corporation Luce-kai Bene Asakusa Health Checkup Clinic

hrssasaki0226@gmail.com03-6802-7910

Outcome results